Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 5.28 Delayed Data As of Jan 21 |  +0.18 / +3.53%Today’s Change | 5.00 Today|||52-Week Range 15.86 | -36.46% Year-to-Date |
Latest DNA News | Press Releases
| Gleason Group, Inc. Buys Herc Holdings Inc, DocuSign Inc, Arhaus Inc, Sells Centene Corp, ... Jan 18 / GuruFocus News - Paid Partner Content | Ginkgo Bioworks Holdings, Inc. (DNA) Could Find Support Soon, Here's Why You Should Buy the Stock Now Jan 11 / Zacks.com - Paid Partner Content |
| Guild Investment Management, Inc. Buys The Mosaic Co, ProShares S&P 500 Dividend ... Jan 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 5.10 |
| Today’s open | 5.06 |
| Day’s range | 5.02 - 5.65 |
| Volume | 20,626,742 |
| Average volume (3 months) | 9,232,552 |
| Market cap | $8.9B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 59,000.00 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$5.0K |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
